| Name |
Recombinant Human CEACAM-19 Fc Chimera Protein, CF
|
| Supplier |
R&D Systems
|
| Catalog |
9397-CM
|
| Category |
Protein
|
| Prices |
$329.00
|
| Sizes |
50 µg
|
| Species Reactivities |
Human
|
| Nature |
Recombinant
|
| Source |
Human embryonic kidney cell, HEK293-derived Human CEACAM-19 (Ala33-Gly157) Accession # Q7Z692-1 IEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus
|
| Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Measured by the ability of the immobilized protein to support the adhesion of the L Cells mouse fibroblast cell line. The ED 50 for this effect is 0.4-2.4 μg/mL
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| SwissProt/Accession |
Q7Z692-1
|
| Gene |
CEACAM19
|
| Sequence |
Ala33
|
| Supplier Page |
Shop
|
Immobilized Recombinant Human CEACAM-19 (Catalog # 9397-CM)enhances L Cells mouse fibroblasts adhesion. The ED 50 for this effect is 0.4-2.4 μg/mL.